BoW Ho

Title: Innovations of BoW Ho in Antimicrobial Therapy

Introduction

BoW Ho is a prominent inventor based in Singapore, known for his significant contributions to the field of antimicrobial therapy. With a total of 9 patents to his name, he has focused on developing innovative solutions for treating gram-negative bacterial infections.

Latest Patents

One of his latest patents involves Factor C, which is crucial for treating gram-negative bacterial infections. Recombinant fragments of Factor C have been disclosed, showcasing their potency in recognizing, binding to, neutralizing, and removing endotoxin. These proteins and peptides are designed for use in anti-microbial, anti-endotoxin, and anti-sepsis therapy. SSCrFCES, a 38 kDa protein representing the LPS-binding domain of Factor C, has demonstrated superior affinity for endotoxin. The endotoxin-neutralizing capability of SSCrFCES has been validated in vitro and in vivo, indicating its potential for treating endotoxin-induced septic shock.

Career Highlights

BoW Ho is affiliated with the National University of Singapore, where he conducts research and develops innovative therapeutic solutions. His work has led to significant advancements in understanding and combating the effects of endotoxins in bacterial infections.

Collaborations

Some of his notable coworkers include Jeak Ling Ding and Nguan Soon Tan, who have collaborated with him on various research projects.

Conclusion

BoW Ho's innovative work in the field of antimicrobial therapy highlights his commitment to advancing medical science and improving treatment options for serious infections. His contributions are paving the way for new therapeutic strategies against gram-negative bacterial infections.